Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2010
09/22/2010EP2229380A1 Polymorphic forms of a 3-pyrrole substituted 2-indolinone
09/22/2010EP2229369A1 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
09/22/2010EP2229187A2 Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (ptk7)
09/22/2010EP2229170A1 Kinesin inhibitors as cancer therapeutics
09/22/2010EP2044078B1 Camptothecin derivatives with antitumor activity
09/22/2010EP2029552B1 Sulfimides as protein kinase inhibitors
09/22/2010EP1962094B1 Detecting agent and therapeutic agent for highly malignant breast cancer
09/22/2010EP1812440B1 Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
09/22/2010EP1773791B1 Pyrrolotriazine compounds
09/22/2010EP1765830B1 Mitotic kinesin inhibitors
09/22/2010EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
09/22/2010EP1490374B1 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
09/22/2010EP1450850B1 Method of administering a thymosin alpha 1 peptide
09/22/2010EP1436313B1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
09/22/2010EP1401853B1 Modulators of pharmacological agents
09/22/2010CN1970015B Enzymatic extraction method of pawpaw polyphenol
09/22/2010CN1947722B Blood sugar regulator used during user having meals and its preparation method
09/22/2010CN1893961B Biologically active blood serum obtained by electroshock
09/22/2010CN1852708B Human beta-defensin secretion promoter
09/22/2010CN1693416B Fluorescent microball and process and application for preparing spray drying thereof
09/22/2010CN1612746B Use of HEPCIDIN as a regulator of iron homeostasis
09/22/2010CN1545422B Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingred
09/22/2010CN101842490A Antigenic compositions and use of same in the targeted delivery of nucleic acids
09/22/2010CN101842390A Antibodies against RAMP3
09/22/2010CN101842389A Anti-cd20 therapeutic compositions and methods
09/22/2010CN101842362A Benzothiazole compounds
09/22/2010CN101842114A Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
09/22/2010CN101842113A Immune response inducer
09/22/2010CN101838611A Recombinant plasmodium for expressing exogenous gene and application thereof
09/22/2010CN101838601A Wallich wedelia herb health-care yellow wine
09/22/2010CN101838329A Anti-angiogenesis fusion protein
09/22/2010CN101838328A Anti-vegf antibodies
09/22/2010CN101838317A Mimic short peptide 11B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838313A Mimic short peptide 9B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838312A Mimic short peptide 12B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838311A Mimic short peptide 7B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838310A Basic fibroblast growth factor epitope simulative peptide T3 and application thereof
09/22/2010CN101838307A K2 polypeptide synthesis product and application thereof
09/22/2010CN101838306A K4 polypeptide synthesis product and application thereof
09/22/2010CN101838305A T2 peptide synthesis product and application thereof
09/22/2010CN101838289A Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
09/22/2010CN101838284A Dibutyltin oxide coordination compound and preparation method and application thereof
09/22/2010CN101838261A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/22/2010CN101838248A 1,4-naphthoquinone compounds and application thereof
09/22/2010CN101838201A Phenol compounds and application thereof
09/22/2010CN101837134A Chronic myeloid leukemia DNA vaccine BCR/ABL-pIRES-SEA and preparation method and application thereof
09/22/2010CN101837131A Application of cancer gene ALCl (Anaplasitc Large Cell Lymphoma) in liver cancer treatment
09/22/2010CN101837130A Polyethylene glycol-dipeptide-antitumour drug complex and use thereof
09/22/2010CN101837129A Medicament composition containing cMet inhibitor, HDAC (Histone Deacetylases) inhibitor and EGFR (Epidermal Growth Factor Receptor) tyrosine kinase inhibitor and application thereof
09/22/2010CN101837128A Medicament composition containing sorafenib, MEK inhibitors and EGFR tyrosine kinase inhibitors and application thereof
09/22/2010CN101837127A Medical use of inhibitors of glutaminyl and glutamate cyclases
09/22/2010CN101837124A Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
09/22/2010CN101837123A Tumor cell vaccine and preparation method thereof
09/22/2010CN101837122A Genetic engineering composite peptide vaccine for inhibiting tumor angiogenesis and use thereof
09/22/2010CN101837108A Liver and kidney yin-nourishing soup
09/22/2010CN101837091A Process for continuously extracting polygonatum saponin and polygonatum polysaccharose
09/22/2010CN101837066A Application of golden thread detoxication decoction as compound preparation in preparing IOD active medicaments
09/22/2010CN101837065A Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof
09/22/2010CN101837059A Method for preparing apple polyphenol
09/22/2010CN101837058A Medicament for curing leukemia
09/22/2010CN101837050A Medicament for curing lung cancer and preparation method thereof
09/22/2010CN101837034A Method for extracting radix achyranthis bidentatae saponin
09/22/2010CN101837032A Blueberry anthocyanin oral solution
09/22/2010CN101837029A Nanometer taxus chinensis powder and preparation method thereof
09/22/2010CN101837027A Chinese medicinal preparation for inhibiting cancer cell line and preparation method thereof
09/22/2010CN101837002A Anti-cancer sustained-release injection
09/22/2010CN101836992A Application of 4-benzothiopheneaminoquinazoline derivative in preparing tumor treatment medicine
09/22/2010CN101836991A Medicament composition containing sorafenib, cMet inhibitors and EGFR tyrosine kinase inhibitors and application thereof
09/22/2010CN101836989A Medicament composition containing tetrandrine, tetrandrine derivatives and histone deacetylase inhibitor and application thereof
09/22/2010CN101836988A Anti-tumor activity of derivative of polyhalogenated isoquinoline imine
09/22/2010CN101836980A Medical uses of 39-desmethoxyrapamycin and analogues thereof
09/22/2010CN101836979A Medication application of 4-tert-butyl-5-(1,2,4-triazol-1-yl)-2-benzyliminothiazole
09/22/2010CN101836976A Application of icaritin in preparation of anti-angiogenic medicaments
09/22/2010CN101836962A Method for preparing bendamustine hydrochloride freeze-dried powder injection
09/22/2010CN101836958A Preparation of taxane pH sensitive nanoparticles composite for oral administration and application thereof
09/22/2010CN101332276B Traditional Chinese medicine for treating uterus tumour
09/22/2010CN101301289B Uses of berberine and analog thereof in pump for reversing multidrug resistance
09/22/2010CN101249133B Medicament for treating leukemia and manufacturing method
09/22/2010CN101234089B Alkaline fibroblast growth factor liposome vaccine and preparation method and application thereof
09/22/2010CN101225066B Cyclohexenone extract of antrodia camphorata
09/22/2010CN101181573B Medicine for curing tumor and preparation method thereof
09/22/2010CN101180042B Conjugate of biomacromolecule with bioreductive and preparative method thereof
09/22/2010CN101129493B Antineoplastic anti-AIDS pharmaceutical composition and method of preparing the same
09/22/2010CN101129335B Use of nano structured lipid carrier drug feeding system
09/22/2010CN101002931B Ubenimex tablet and its preparing method
09/21/2010US7799955 such as 1-(2,4-dimethoxyphenyl)-2-(3,4-methoxyphenyl)-prop-2-en-1-one, used in the prevention of menopausal symptoms, headaches, osteoporosis, rheumatic diseases, atherosclerosis, hypertension, benign prostatic hyperplasia, cancer and inflammatory diseases
09/21/2010US7799901 capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 (mediators of receptor toxicity) protein
09/21/2010US7799899 Compositions and methods relating to STOP-1
09/21/2010US7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
09/21/2010US7799896 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799819 chronic lymphocytic leukemia or acute lymphoblastic leukemia; use of specific compound (1R)-cyclopropanecarboxylic acid {2-[2-carbamoyl-1-(3-ethoxy-4-methoxy-phenyl)-ethyl]-7-chloro-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
09/21/2010US7799811 administering 1-[4-(4-chlorophenyl)-1,2,5-oxadiazol-3-yl]-3-[4-(trifluoromethyl)phenyl]urea, as antiproliferative or anticarcinogenic agents and as antagonists of signal transducers and activators of transcription (STAT) proteins
09/21/2010US7799787 pyridazine derivatives such as N-(2-Cyclopropylethyl)-6-{4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl}pyridazine-3-carboxamide, useful for the prevention and treatment of dyslipidemia, obesity, diabetes, syndrome X, insulin resistance, fatty liver, cancer, cardiovascular and nervous system disorders
09/21/2010US7799781 5,6,7,8-tetrahydropteridine derivatives as HSP90 inhibitors
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate
09/21/2010US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
09/21/2010US7799353 Pharmaceutical mixture for hepatitis treatment and its preparation method
09/21/2010US7799329 Viruses for the treatment of cellular proliferative disorders
1 ... 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 ... 2211